Ophthalmology Risk Minimisation Materials
EYLEA® (aflibercept)

Here you can find links to the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for EYLEA® (aflibercept), via the Electronics Medicines Compendium (eMC), a resource providing information about all medicines available in the UK. Please note that this information is specific to the United Kingdom and is not intended to replace the advice of a qualified doctor. For more information on EYLEA or any related support, please contact the Bayer Medical Information team on
Prescriber guide
Prescriber guide video
Prescribing information for EYLEA® (aflibercept)
EYLEA patient guides
All patient guides are recertified for use with original date of preparation.

Wet age-related macular degeneration (wAMD)
PP-EYL-GB-2647 | December 2024


